Evidence map›Paper›PMID 40794384›Full record

ArticlePurinergic signalling2025

Adenine at lower doses acts in the kidney as an aquaretic agent and prevents hyponatremia.

Alaa Alghamdi, Charuhas V Thakar, Hassane Amlal

Abstract read
In one paragraph

Article in Purinergic signalling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Heat-KilledJournal of microbiology and biotechnology · 2026
    Article
  2. International journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alaa AlghamdiDepartment of Pharmacology and Systems Physiology, College of Medicine, University of Cincinnati, Cincinnati, OH, 45267, USA.
Charuhas V ThakarDepartments of Internal Medicine, Division of Nephrology & Hypertension, College of Medicine, University of Cincinnati, 231 Albert Sabin Way, MSB, Room 6213, Cincinnati, OH, 45267, USA.
Hassane AmlalDepartments of Internal Medicine, Division of Nephrology & Hypertension, College of Medicine, University of Cincinnati, 231 Albert Sabin Way, MSB, Room 6213, Cincinnati, OH, 45267, USA. Amlalh@uc.edu.

Funding

Dialysis Clinics C-4095 and C-4192
6 · The paper itself

Abstract

We have previously reported that adenine at high doses interferes with the vasopressin signaling pathway, causes massive diuresis and volume depletion, and ultimately leads to renal failure. In the present study, we examined the effects of adenine on renal salt and water handling in a time course and dose-response study in rats housed in metabolic cages and fed control or adenine-containing diet at 1500, 2000, 2500 mg/kg and euthanized after 1, 3, and 7 weeks. Adenine at 2000 and 2500 mg/kg caused early and significant polyuria, polydipsia, and decreased urine osmolality in a dose-dependent manner without significantly affecting food intake, blood volume, blood electrolyte levels, or acid-base composition. The impaired water balance resulted from the downregulation of apical water channel AQP2 in the outer and inner medulla but not in the cortex. Adenine did not alter electrolytes (Na

Indexed as

AdenineHyponatremiaKidneyAnimalsAquaporin 2Dose-Response Relationship, DrugMaleRatsRats, Sprague-DawleyRats, WistarWater-Electrolyte BalanceAdenineAquaporin 2AdenineAQP2AquaresisHyponatremiaVasopressin resistance

Identifiers

PMID40794384
PMCPMC12722628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.